Evidence map›Paper›PMID 37107633›Full record

ArticleGenes2023

Occurrence of High-Risk Clonal Lineages ST58, ST69, ST224, and ST410 among Extended-Spectrum β-Lactamase-Producing

Saloua Benlabidi, Anis Raddaoui, Sana Lengliz, Sarah Cheriet, Paul Hynds, Wafa Achour, Taoufik Ghrairi, Mohamed Salah Abbassi

Abstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Genomic Epidemiology of ESBL and Non-ESBL-ProducingAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Review
  8. Fosfomycin-resistantJAC-antimicrobial resistance · 2025
    Article
  9. Article
  10. Article
  11. A Systematic Review and Comprehensive Analysis ofAntibiotics (Basel, Switzerland) · 2024
    Review
  12. The Global Rise of ESBL-ProducingAnimals : an open access journal from MDPI · 2024
    Review
  13. Article
  14. Antimicrobial agents and chemotherapy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Saloua BenlabidiInstitute of Veterinary Research of Tunisia, University of Tunis El Manar, Tunis 1006, Tunisia.
Anis RaddaouiLaboratory Ward, National Bone Marrow Transplant Center, Tunis 1006, Tunisia.ORCID 0000-0003-0293-9735
Sana LenglizInstitute of Veterinary Research of Tunisia, University of Tunis El Manar, Tunis 1006, Tunisia.
Sarah CherietInstitute of Veterinary Research of Tunisia, University of Tunis El Manar, Tunis 1006, Tunisia.
Paul HyndsEnvironmental Sustainability and Health Institute (ESHI), Technological University Dublin, D07 H6K8 Dublin, Ireland.ORCID 0000-0002-1260-2688
Wafa AchourLaboratory Ward, National Bone Marrow Transplant Center, Tunis 1006, Tunisia.ORCID 0000-0002-7245-9190
Taoufik GhrairiLaboratory of Neurophysiology Cellular Physiopathology and Biomolecule Valorisation LR18ES03, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 1068, Tunisia.
Mohamed Salah AbbassiInstitute of Veterinary Research of Tunisia, University of Tunis El Manar, Tunis 1006, Tunisia.ORCID 0000-0001-9673-193X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial-resistant

Indexed as

ChickensEscherichia coliAnimalsbeta-LactamasesClone CellsMultilocus Sequence TypingTunisiabeta-LactamasesCTX-M-1ESBLEscherichia colifree-range chickenshigh-risk clonemcr-2

Identifiers

PMID37107633
PMCPMC10138121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.